Lutetium-177 Industry Research Report 2024: Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177 - Global Forecast 2024-2030
September 09, 2024 04:56 ET
|
Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Lutetium-177 Market by Form (Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177), Route of Administration (Intravenous, Oral), End User,...
Global Cushings Syndrome and Acromegaly Treatment Market Analysis Report 2024-2031 Featuring Novartis, Corcept Therapeutics, HRA Pharma, Bristol-Myers Squibb, Pfizer, & Ipsen Biopharmaceuticals
July 30, 2024 09:59 ET
|
Research and Markets
Dublin, July 30, 2024 (GLOBE NEWSWIRE) -- The "Cushings Syndrome and Acromegaly Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
Octreotide Market Size, Forecast, and Developments Through 2032
May 03, 2024 05:46 ET
|
Research and Markets
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Octreotide Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report provides an...
Somatostatin Analogs Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 - Opportunities in the Acromegaly and Neuroendocrine Tumor Markets
February 16, 2024 05:18 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.The...
Global Somatostatin Analogs Market to Reach $8.67 Billion by 2028 - Forecast Shows Rapid Growth in Asia-Pacific and Innovation Trends
January 25, 2024 05:42 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for somatostatin...
Neuroendocrine Tumor Treatment Market Set to Surge with Innovative Therapies and Global Expansion
January 23, 2024 02:43 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumor Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The neuroendocrine tumor...
Lutathera and Pepaxto Dominated the Peptide Drug Conjugates Market in 2022
October 18, 2023 10:03 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Peptide Drug Conjugates Market Size, Share & Trends Analysis Report By Product (Lutetium, Melflufen, ANG1005, BT1718, CBX-12, Other Pipeline), By...
Global Somatostatin Analogs Market Intelligence Report to 2027 - Featuring CVS Health, Ipsen Pharma and Pfizer Among Others
July 25, 2022 06:43 ET
|
Research and Markets
Dublin, July 25, 2022 (GLOBE NEWSWIRE) -- The "Somatostatin Analogs Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market
October 14, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
Global Neuroendocrine Tumors (NET) Market Spotlight 2020-2028
March 04, 2021 06:48 ET
|
Research and Markets
Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Neuroendocrine tumors (NET)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the...